419571-53-2

Pyrazolo[1,5-a]pyridine, 2-ethyl-4,5,6,7-tetrahydro-

3-Penten-1-yne, 3-(1,1-dimethylethyl)-5,5-diethoxy-

Benzenamine, 4,4'-[[4-[2-(4-pyridinyl)ethenyl]phenyl]methylene]bis-

2-BROMO-6-NITRO-4-[(TRIFLUOROMETHYL)SULPHONYL]PHENOL 95%

4H-1,2,4-Triazole,3-[1-(4-chlorophenyl)cyclobutyl]-4-methyl-5-[4-(trifluoromethyl)phenyl]-

4H-1,2,4-Triazole,3-[[[3-(3-chlorophenyl)-5-isoxazolyl]methyl]thio]-4-ethyl-5-(2-furanyl)-

4H-1,2,4-Triazole,3-[[[5-(3-chlorophenyl)-3-isoxazolyl]methyl]thio]-4-ethyl-5-(trifluoromethyl)-

3-Pentanone, 2-bromo-4-methyl-

3-Piperidinecarboxamide,1-methyl-N-[(1S)-7-oxo-1-[[(4-phenyl-2-thiazolyl)amino]carbonyl]octyl]-

3-Penten-2-ol,1-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-5-[2-[tris(1-methylethyl)silyl]-1,3-dithian-2-yl]-, (3E)-

3-Penten-1-one, 4-methoxy-1,2,3-triphenyl-, (E)-

3-Pentanone, 4,4-dimethyl-1-phenyl-1-(1H-1,2,4-triazol-1-yl)-,hydrochloride

3-Penten-2-one, 4-(acetyloxy)-, (E)-

3-Piperidinecarboxamide,1-[7-[(2-chloro-6-fluorophenyl)methyl]-2,3,6,7-tetrahydro-1,3-dimethyl-2,6-dioxo-1H-purin-8-yl]-N-(2-methoxyethyl)-N-methyl-

3-Pentanone, 2,4-dimethyl-2-(methylthio)-

3-Penten-2-one, 3-[(4,6-dimethyl-2-pyrimidinyl)thio]-4-hydroxy-,monoperchlorate (salt)

3-Piperidinecarboxamide,1-[7-[(2-chloro-6-fluorophenyl)methyl]-2,3,6,7-tetrahydro-1,3-dimethyl-2,6-dioxo-1H-purin-8-yl]-N-pentyl-

4H-1,2,4-Triazole,3-[[[5-(3-chlorophenyl)-2-oxazolyl]methyl]thio]-4-ethyl-5-(2-furanyl)-

3-Piperidinecarbonitrile, 6-hydroxy-6-methyl-5-nitro-4-phenyl-2-thioxo-,(4R,5R)-rel-, compd. with morpholine (1:1)

4H-1,2,4-Triazole-3-methanol,5-[[[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]thio]-4-ethyl-

4H-1,2,5-Oxadiazine, 5,6-dihydro-5-methyl-

3-Penten-1-one, 2-hydroxy-1-phenyl-, (E)-

3-Piperidinecarboxamide,N-[(1R)-1-[(4-chlorophenyl)methyl]-2-[4-[2-[(methylsulfonyl)amino]phenyl]-1-piperazinyl]-2-oxoethyl]-

3-Pentanone, 4,4-dimethyl-1-(2-pyridinyl)-1-(1H-1,2,4-triazol-1-yl)-

4H-1,2,4-Triazole,4-cyclopropyl-3-[1-(4-fluorophenyl)cyclobutyl]-5-(1-methylcyclopropyl)-

4H-1,3,2-Benzodioxaphosphorin, 2-(butylthio)-, 2-oxide

4H-1,2,4-Triazole-3-acetonitrile, 4-phenyl-

4H-1,2,4-Triazole-4-propanoic acid,3-[(1S)-1-[(2-amino-2-methyl-1-oxopropyl)amino]-2-(phenylmethoxy)ethyl]-5-[(1,1-dimethylethyl)thio]-, methyl ester

3-Penten-1-ol, 2-methyl-5-(phenylmethoxy)-, (2S,3Z)-

3-Piperidinecarboxamide,N-[3-[2-(1H-benzimidazol-4-yl)-6-(4-morpholinyl)-4-pyrimidinyl]phenyl]-

3-Piperidinecarboxamide,1-[5-(3,4-difluorophenyl)-2-pyridinyl]-N-(4-hydroxycyclohexyl)-, (3S)-

4H-1,3,2-Benzodioxasilin-4-one, 2,2-diethoxy-

3-Piperidinecarboxamide, 1-acetyl-N-methyl-, (3R)-

3-Piperidinecarboxamide, N-(4-bromophenyl)-1-(3-pyridinylsulfonyl)-

3-Piperidinecarboxamide,N-[3-[3-(1-pyrrolidinylmethyl)phenoxy]propyl]-, ethanedioate (1:2)

3-Piperidinecarboxamide, N-[4-(4-pyridinyl)-2-thiazolyl]-

3-Piperidinecarboxamide,N-(trans-4-hydroxycyclohexyl)-1-[(2-nitrophenyl)sulfonyl]-, (3S)-

419571-53-2 msds

CAS No 419571-53-2 supplier

CASNo 419571-53-2 distributor

CAS # 419571-53-2 manufacturer

CAS Number 419571-53-2 safety

CAS RN 419571-53-2 wholesale

2026-10-10 Find Pyrazolo[1,5-a]pyridine, 2-ethyl-4,5,6,7-tetrahydro-,CAS No.419571-53-2,Formula:C9H14N2 in ChemGloble